Cedars-Sinai Cardiologist Joins Recom Managed Systems Board Of Directors.

Business Editors & Health/Medical Writers

LOS ANGELES--(BUSINESS WIRE)--Feb. 13, 2003

Recom Managed Systems, Inc. (OTCBB:RECM) has announced the appointment of Robert Koblin, M.D. to the Company's Board of Directors.

Dr. Koblin is a highly respected and experienced cardiologist and entrepreneur who brings extensive operational and medical experience to Recom's Board of Directors. Dr. Koblin's medical experience spans more than 30 years, beginning during the time he served in the United States Army as a medic and continuing most recently as a staff physician and instructor at the prestigious Cedars-Sinai Medical Center in Los Angeles.

Dr. Koblin currently serves as the Managing Director of the Robertson Diagnostic Center in Beverly Hills, CA. The state of the art center is currently augmenting its diagnostic capabilities in order to provide nuclear cardiology, echo-cardiography, holter monitoring, monitoring of pulmonary functions and bone density studies. Dr. Koblin is also an attending physician instructor and has actively served on the Bioethics Committee and Coronary Care Units Committee at Cedars-Sinai Medical Center. In addition, Dr. Koblin is an assistant clinical professor of medicine at the University of California, Los Angeles (UCLA).

On Dr. Koblin's acceptance, Marvin H. Fink, Recom's Chief Executive Officer commented: "I believe the addition of Dr. Koblin will greatly benefit the company as we continue to advance on our goals related to product development and the acceptance of our product by the medical community. The benefit is obvious: It gives us the complete insight to how our technologies, if developed fully, would assist real human beings and real patients in a clinical setting." Additionally, the acceptance of a renowned cardiologist such as Dr. Koblin to our Board of Directors is a further testament to the quality of our technology and the promise that our product hold for medical science in the future."

After viewing the initial comparison results with Company's personal heart monitor and General Electric's (NYSE:GE) MAC 5000 System, originally reported in Recom's January 21, 2003 press release, Dr. Koblin had to say: "The technology I have witnessed today is revolutionary and has the ability to make all other ambulatory heart monitoring devices obsolete. The technology's possible impact on the state of monitoring science is one of the main reasons I have accepted the invitation to join the company's board of directors. If Recom can develop the technology into a workable device, cardio-vascular disease as we currently know it will be managed at an exponentially lower cost to society and the individual patients."

About Recom Managed Systems

Recom Managed Systems, Inc., a Delaware corporation, is an emerging life sciences company. In September, 2002, Recom completed a technology acquisition for purposes of attempting to develop and then commercialize heart monitoring devices. Notwithstanding this transaction, Recom intends for the foreseeable future to remain a development-stage company with negligible cash or other tangible assets, no currently outstanding debt and no immediate prospects of revenue. Recom will require substantial additional money to fund further development and continue with attempts to commercialize the technology into products and services. Recom cannot provide assurances that any of these endeavors will be successful.

Caution Regarding Forward-Looking Statements

Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Recom's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to failure to complete the development and introduction of new products or services, failure to obtain federal or state regulatory approvals governing medical devices, monitoring and other related services or products, inability to obtain physician, patient or insurance acceptance of Recom's products or services, adverse equity market conditions and declines in the value of Recom's common stock, and the unavailability of financing to complete management's plans and objectives. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Recom's filings with the Securities and Exchange Commission, including, but not limited to, the Form 8-K which was filed in September 2002.